Successful control of dasatinib-related chylothorax by the Japanese Herbal Medicine “Goreisan”

Hisashi Sasaki, Yoshifumi Kimizuka, Hiraku Ogata, Yosuke Okada, Shinichiro Ota, Tomoya Sano, Chie Watanabe, Yohei Maki, Takayuki Yamamoto, Yoichi Tagami, Jun Miyata, Nobuyoshi Hayashi, Yuji Fujikura, Akihiko Kawana

研究成果: Article査読

5 被引用数 (Scopus)

抄録

Dasatinib-related chylothorax is a rare adverse event, and the mechanism underlying its occurrence is still not fully understood. We herein report the case of a 73-year-old woman with chronic myeloid leukemia (CML) who developed dasatinib-related chylothorax refractory to conventional treatments, except for steroids. To the best of our knowledge, this is the first case of dasatinib-related chylothorax which was successfully controlled by combining diuretics with the Japanese herbal medicine “Goreisan.” “Goreisan” is known to inhibit aquaporin channels and regulate the water flow. Our findings showed that “Goreisan” is an effective treatment option for uncontrollable dasatinib-related chylothorax.

本文言語English
ページ(範囲)3139-3141
ページ数3
ジャーナルInternal Medicine
58
21
DOI
出版ステータスPublished - 2019
外部発表はい

ASJC Scopus subject areas

  • 内科学

フィンガープリント

「Successful control of dasatinib-related chylothorax by the Japanese Herbal Medicine “Goreisan”」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル